
The manufacturers of Americas most used COVID-19 vaccines insist they have plans in place to quickly adapt to potential challenges presented by the new omicron variant.
Both Pfizer and vaccine partn… [+2010 chars]

The manufacturers of Americas most used COVID-19 vaccines insist they have plans in place to quickly adapt to potential challenges presented by the new omicron variant.
Both Pfizer and vaccine partn… [+2010 chars]